Poliorix inj. sol. i.m. vial

Valsts: Beļģija

Valoda: angļu

Klimata pārmaiņas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktīvā sastāvdaļa:

Poliomyelitis Virus, Inactivated

Pieejams no:

GlaxoSmithKline Biologicals SA-NV

ATĶ kods:

J07BF03

SNN (starptautisko nepatentēto nosaukumu):

Poliomyelitis Virus

Zāļu forma:

Solution for injection

Kompozīcija:

Poliomyelitis Virus

Ievadīšanas:

Intramuscular use

Ārstniecības joma:

Poliomyelitis, Trivalent, Inactivated, Whole Virus

Produktu pārskats:

CTI code: 240371-01 - Pack size: 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 240371-05 - Pack size: 50 x 5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 240371-04 - Pack size: 10 x 5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 240371-03 - Pack size: 5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 240371-02 - Pack size: 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 240371-09 - Pack size: 100 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 240371-08 - Pack size: 10 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 240371-07 - Pack size: 100 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 240371-06 - Pack size: 10 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Autorizācija statuss:

Commercialised: No

Autorizācija datums:

2002-10-14